Lumida
/ABEO
⌘K
Abeona Therapeutics Inc

Abeona Therapeutics Inc

ABEO
$5.85USD-1.18%-0.07 today

MARKET CAP

334.5M

P/E (TTM)

6.0x

FWD P/E

DAY RANGE

$6 – $6

52W RANGE

$4
$8

AI Summary

Stalk
StalkMedium

In a Stage 2 advance with clear higher highs and higher lows, price has broken above a key pivot but is currently extended and overbought. Speculative engagement should be deferred until a pullback into the rising EMA 9/21/50 cluster confirms support.

  • Q1 2026 revenue jumped 262% QoQ to $8.7 M on initial ZivaSkin treatments
  • CMS granted NTAP status for ZivaSkin, improving reimbursement rates
  • Q1 2026 net loss was $17.1 M with SG&A up to $19.5 M
Full analysis →

Buying

2

institutions

Selling

6

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY3.35 M20.72 M+156.94 K+44.7%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY454.40 K2.81 M+166.36 K+117.6%0.00%
MM

Millennium Management LLC

Q2 2026

SELL211.34 K1.31 M+-214.09 K-31.5%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL67.06 K414.45 K+-35.58 K-9.9%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL50.51 K285.86 K+-215.99 K-74.6%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL0.000.00+-589.85 K-100.0%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL0.000.00+-161.08 K-100.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-29.26 K-100.0%0.00%